Sunday, June 1, 2025

Latest

Cronos Group Appoints Kurt Schmidt As CEO, Gorenstein Appointed Executive Chairman

Cronos GRoup (TSX: CRON) (NASDAQ: CRON) this morning announced that Mike Gorenstein will be stepping aside as both President and CEO of the firm, while remaining with the company in the role of executive chairman. Taking his place will be that of Kurt Schmidt, whom comes with experience from executive roles at Blue Buffalo Company, Nestle S.A., Gerber and Kraft Foods.

Schmidt’s experience within the consumer goods sector is quite extensive, with him most recently served as CEO of Blue Buffalo Company. Prior to this, he served as deputy executive vice president at Nestle S.A., following its acquisition of Gerber in 2007, where Schmidt was president and CEO. Schmidt also serves on the board of directors for the Campbell Soup Company.

Commenting on his appointment, Schmidt identified that he will be focused on “building outstanding brands,” along with standard commentary related to being results driven. The company expects to lean on his extensive CPG background to push the company forward.

We’ve built a premier global cannabinoid Company with a portfolio of innovative technology, differentiated consumer brands, an excellent team, a fortress balance sheet and a strong strategic partner. Over the past year, I’ve led a search for an experienced consumer focused executive who shares the Company’s values and can help take us to the next level.

Mike Gorenstein, Executive Chairman of Cronos Group

Cronos Group last traded at $5.24 on the Nasdaq.


Information for this briefing was found via Sedar and Cronos Group. The author has no securities or affiliations related to these organizations. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Alamos Gold Q1 Earnings: The Inside Scoop

Cerrado Gold Q4 Earnings: The Turnaround is Working

B2GOLD Q1 Earnings: Revenue Up, Production & Cash Flow Decline

Recommended

Canadian Copper: The $172M Combined Strategy PEA

ESGold Begins Concentration Tests Ahead Of First Production

Related News

Medipharm Labs and Cronos Group Sign Second Manufacturing Agreement

Medipharm Labs (TSX: LABS) and Cronos Group (TSX: CRON) (NASDAQ: CRON) have entered into their...

Thursday, September 19, 2019, 09:23:17 AM

Cronos Group Sees CEO Retire, Gorenstein Returns To Helm

After less than two years on the job, Kurt Schmidt has retired as the chief...

Monday, March 21, 2022, 08:32:05 AM

Cronos Group Further Delays Filings, Reduces Prior Revenue Figures By $7.6 Million

Cronos Group (TSX: CRON) (NASDAQ: CRON) announced this evening that further to it’s previous release,...

Tuesday, March 17, 2020, 05:18:09 PM

Heritage Cannabis Director Resigns Just Ahead Of Year End

When we last checked in with our favorite Canadian extraction play Heritage Cannabis (CSE:CANN) in...

Tuesday, February 11, 2020, 08:45:11 AM

Canadian Cannabis: Canaccord Lifts Cronos Target, Reiterates Canopy Growth And Tilray Ratings

Yesterday Canaccord Genuity Capital Markets put out a second-quarter preview note on the top Canadian...

Thursday, July 28, 2022, 03:02:00 PM